Cargando…

Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies

The increasing prevalence of inflammatory bowel disease and the high costs associated with biologic therapies suggest that biologics with lower costs, but no compromise on efficacy and safety, should be considered when developing a treatment plan for inflammatory bowel disease. Biosimilars offer a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Armuzzi, Alessandro, Avedano, Luisa, Greveson, Kay, Kang, Taegyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357893/
https://www.ncbi.nlm.nih.gov/pubmed/30285235
http://dx.doi.org/10.1093/ecco-jcc/jjy150